Evolution Wealth Advisors’s Myovant Sciences Ltd. MYOV Stock Holding History

Evolution Wealth Advisors’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-288	Closed	-$6K	–	663
2021 Q3	$6K	Sell	288 -439	-60%	-$9.64K	﹤0.01%	492
2021 Q2	$17K	Sell	727 -139,500	-99%	-$2.93M	﹤0.01%	331
2021 Q1	$2.89M	Hold	140,227	–	–	0.64%	36
2020 Q4	$3.87M	Buy	140,227 +68,516	+96%	+$1.33M	0.87%	32
2020 Q3	$1.01M	Buy	71,711 +70,935	+9,141%	+$1.32M	0.28%	50
2020 Q2	$16K	Sell	776 -330	-30%	-$4.49K	0.01%	232
2020 Q1	$8K	Buy	1,106 +200	+22%	+$2.24K	﹤0.01%	223
2019 Q4	$14K	Buy	906 +797	+731%	+$8.03K	﹤0.01%	260
2019 Q3	$1K	Sell	109 -502	-82%	-$3.72K	﹤0.01%	472
2019 Q2	$6K	Buy	+611	New	+$9.11K	﹤0.01%	252

Other funds holding MYOV

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Evolution Wealth Advisors's MYOV Position: Q4 2021 in Review

Evolution Wealth Advisors sold out of Myovant Sciences Ltd. (MYOV) in Q4 2021, closing a stake of 288 shares — an estimated $6K sold.

Evolution Wealth Advisors first reported a position in MYOV in Q2 2019 and held it in 10 quarters. The position peaked at $3.87M in Q4 2020. 110 funds tracked by Wall St. Rank hold MYOV as of Q4 2021.

Evolution Wealth Advisors reported no remaining Myovant Sciences Ltd. position as of Q4 2021 after selling out during the quarter.
Evolution Wealth Advisors sold 288 Myovant Sciences Ltd. shares in Q4 2021, an estimated $6K.
Evolution Wealth Advisors first reported a position in Myovant Sciences Ltd. in Q2 2019 and held it in 10 quarters.
Evolution Wealth Advisors's Myovant Sciences Ltd. position peaked at $3.87M in Q4 2020.
110 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2021.

Based on Evolution Wealth Advisors's 13F filing for Q4 2021, filed 28 Jan 2022.